460 related articles for article (PubMed ID: 28359079)
1. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
[TBL] [Abstract][Full Text] [Related]
2. The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer.
Smith CR; Chiarelli AM; Holloway CM; Mirea L; O'Malley FP; Blackmore KM; Pandya A; Majpruz V; Harris CP; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D
Breast; 2018 Oct; 41():25-33. PubMed ID: 29957557
[TBL] [Abstract][Full Text] [Related]
3. Comparison of wait times across the breast cancer treatment pathway among screened women undergoing organized breast assessment versus usual care.
Blackmore KM; Weerasinghe A; Holloway CMB; Majpruz V; Mirea L; O'Malley FP; Paroschy Harris C; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D; Chiarelli AM
Can J Public Health; 2019 Oct; 110(5):595-605. PubMed ID: 31037608
[TBL] [Abstract][Full Text] [Related]
4. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
[TBL] [Abstract][Full Text] [Related]
5. Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program.
Chiarelli AM; Mai V; Halapy EE; Shumak RS; O'Malley FP; Klar NS
Can J Public Health; 2005; 96(4):259-63. PubMed ID: 16625791
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
7. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
8. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
9. Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program.
Elder K; Nickson C; Pattanasri M; Cooke S; Machalek D; Rose A; Mou A; Collins JP; Park A; De Boer R; Phillips C; Pridmore V; Farrugia H; Bruce Mann G
Ann Surg Oncol; 2018 Sep; 25(9):2563-2572. PubMed ID: 29717421
[TBL] [Abstract][Full Text] [Related]
10. The impact of mammographic screening on the surgical management of breast cancer.
James TA; Wade JE; Sprague BL
J Surg Oncol; 2016 Apr; 113(5):496-500. PubMed ID: 26799535
[TBL] [Abstract][Full Text] [Related]
11. Organized breast screening improves reattendance compared to physician referral: a case control study.
Makedonov I; Gu S; Paszat LF;
BMC Cancer; 2015 Apr; 15():315. PubMed ID: 25928416
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of appropriate short-term mammographic surveillance in patients who undergo breast-conserving Surgery (BCS).
Gunia SR; Merrigan TL; Poulton TB; Mamounas EP
Ann Surg Oncol; 2012 Oct; 19(10):3139-43. PubMed ID: 22872291
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.
Jiang L; Gilbert J; Langley H; Moineddin R; Groome PA
Health Promot Chronic Dis Prev Can; 2018 Oct; 38(10):358-367. PubMed ID: 30303656
[TBL] [Abstract][Full Text] [Related]
15. Mammographic screening for breast cancer in a resource-restricted environment.
Apffelstaedt SP; Dalmayer L; Baatjes K
S Afr Med J; 2014 Apr; 104(4):294-6. PubMed ID: 25118556
[TBL] [Abstract][Full Text] [Related]
16. Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program.
Gold N; Christensen RAG; Arneja J; Aminoleslami A; Anderson GM; Brooks JD
Breast Cancer Res Treat; 2023 Apr; 198(3):523-533. PubMed ID: 36800117
[TBL] [Abstract][Full Text] [Related]
17. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
18. Improving work-up of the abnormal mammogram through organized assessment: results from the ontario breast screening program.
Quan ML; Shumak RS; Majpruz V; Holloway CM; O'Malley FP; Chiarelli AM
J Oncol Pract; 2012 Mar; 8(2):107-12. PubMed ID: 23077438
[TBL] [Abstract][Full Text] [Related]
19. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy.
Ko E; Han W; Lee JW; Cho J; Kim EK; Jung SY; Kang MJ; Moon WK; Park IA; Kim SW; Kim KS; Lee ES; Min KH; Kim SW; Noh DY
Breast Cancer Res Treat; 2008 Nov; 112(1):189-95. PubMed ID: 18060577
[TBL] [Abstract][Full Text] [Related]
20. Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.
Eisen A; Blackmore KM; Meschino WS; Muradali D; Carroll JC; Majpruz V; Warner E; Rabeneck L; Chiarelli AM
Mol Genet Genomic Med; 2018 Mar; 6(2):213-223. PubMed ID: 29368425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
